Yu-Nan Huang

12PUBLICATIONS
16CO-AUTHORS
Molecular targetsAboriginal and Torres Strait Islander theory of change models for healthCancer geneticsPredictive and prognostic markersNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 25, 2026
Cardiorenal Mortality and Safety Outcomes of GLP-1 Receptor Agonists in Type 2 Diabetes With BMI Below 27 kg/m2: A Target Trial Emulation.

|Jul 06, 2026
Comparative 24-month cardiovascular outcomes and biomarker trajectories with semaglutide, empagliflozin, and sitagliptin in people with obesity and type 2 diabetes: a multicenter real-world study.

|Jul 02, 2026
Diabetes-type-specific thyroid safety of GLP-1 receptor agonists: evidence from a large real-world cohort.

|Jun 29, 2026
Neuropsychiatric association of tirzepatide and semaglutide in obesity with and without type 2 diabetes.

|Apr 20, 2026
Associations of Semaglutide With Skeletal Outcomes in People With Obesity, With and Without Type 2 Diabetes: A Target Trial Emulation.

|Dec 12, 2025
Effectiveness of Pre-Transplant Dual GLP-1 Receptor Agonist and SGLT2 Inhibitor Therapy on All-Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: a Target-Trial Emulation.

Yu-Nan Huang, Min-Yu Tsou, Pin-Hung Li

Pageof 2

Frequent Collaborators

4 joint publications

Chung-Hsing Wang

3 joint publications

Wen-Ling Liao

3 joint publications

Pen-Hua Su

3 joint publications

Pen-Hua Su